TFRC and glioma: Zhang Y. et al. (2017) developed DOX- and vincristine-loaded liposomes, which were modified with 2 ligands, i.e., T7, seven-peptide ligand of transferrin receptors (TfR) and DA7R, d-peptide ligand of VEGFR 2 for efficient targeting to glioma.